Data Conversion Laboratory (DCL) and Court Square Group announced a new partnership for global life sciences organizations. Together, DCL and Court Square Group help the pharma industry’s clinical and drug development process by providing content management and content structure solutions that support every stage of the product life cycle. DCL provides content structure to documents that are critical to support the life sciences industry. For example, DCL’s structured product labeling (SPL) work comprises deconstructing forms-based content and image-based PDFs to create structured markup (XML). DCL applies a layer of metadata to facilitate downstream content discovery and delivers final SPL files to the FDA on behalf of clients. Using artificial intelligence and natural language processing, DCL’s content enrichment services improve content discovery for R&D applications during the development of new drugs or reclassification of pharma agents. The new partnership provides pharmaceutical and biotech companies with an integrated solution that supports compliance to complex SPL, EDMS, eCTD, eTMF and global regulatory submissions, while working in a cloud based, validated environment that meets the requirements of 21 CFR Part 11.
https://www.dataconversionlaboratory.com/, https://www.courtsquaregroup.com
